Greater China Digest: Biomissile's Series B; Hashkey eyes funds
Biomissile Biopharmaceutical has secured $28.3 million in a Series B round led by Kequan Fund, set up by Anji Economic Development Zone.
Stay updated with breaking news from Hashkey Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biomissile Biopharmaceutical has secured $28.3 million in a Series B round led by Kequan Fund, set up by Anji Economic Development Zone.
Hong Kong continues to dominate the news as it pushes to become a cryptocurrency hub. After urging crypto experts to build exchanges and companies, the latest updates reveal the nation's new rules allow retail investors to interact with cryptocurrencies. Sources familiar with the updates confirmed that
As Hong Kong takes center stage in the regional crypto business, local firms are trying to expand their customer base. One such firm, HashKey Group, is…
The firm is looking to capitalize on Hong Kong's re-emergence as a potential crypto hub as the city has looked to formulate a clear regulatory structure for digital assets.
HashKey Group, the Hong Kong-based crypto investment firm, hopes to raise funds at a valuation north of $1 billion. The company is in the early innings of…